What is the 13F Pro Quality Score for LITS?

13F Pro ranks Lite Strategy, Inc. (LITS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View LITS's current score at https://13fpro.ai/research/LITS (free sign-up required for the full ranking).

Where does 13F Pro source LITS data?

All Lite Strategy, Inc. fundamentals and ownership data come directly from SEC EDGAR. Lite Strategy, Inc. files with the SEC under CIK 1262104. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is LITS in?

Lite Strategy, Inc. (LITS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is LITS research updated on 13F Pro?

LITS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Lite Strategy, Inc.(LITS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1262104 LITS stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 36 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

LITS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Lite Strategy, Inc. (LITS), a Healthcare sector company. LITS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 36 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q3 2026), Lite Strategy, Inc. reports net income of $-23.7M, free cash flow of $-1.5M. Top institutional holders of LITS by reported 13-F value include RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, CITADEL ADVISORS, based on the most recent SEC filings. LITS trades on the Nasdaq exchange and files with the SEC under CIK 1262104. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LITS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lite Strategy, Inc. directly from SEC EDGAR.

Net Income

Q3 2026

$-23.7M

Free Cash Flow

Q3 2026

$-1.5M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-100.0% YoY

$0.00FY 2025

FY22 $40.7MFY23 $48.8MFY24 $65.3MFY25 $0.00

Net Income

-189.7% YoY

$-15.9MFY 2025

FY22 $-54.0MFY23 $-32.0MFY24 $17.8MFY25 $-15.9M

Operating Income

-220.0% YoY

$-17.5MFY 2025

FY22 $-75.5MFY23 $-36.8MFY24 $14.5MFY25 $-17.5M

EPS (Diluted)

-189.5% YoY

$-2.39FY 2025

FY22 $-9.99FY23 $-4.78FY24 $2.67FY25 $-2.39

Total Assets

-55.8% YoY

$18.3MFY 2025

FY22 $177.8MFY23 $120.8MFY24 $41.4MFY25 $18.3M

Op. Cash Flow

+58.7% YoY

$-20.8MFY 2025

FY22 $-48.7MFY23 $-52.5MFY24 $-50.5MFY25 $-20.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$0.00 -100.0%	$65.3M +33.8%	$48.8M +19.9%	$40.7M +17.0%	$34.8M +25.4%	$27.8M
Net Income	$-15.9M -189.7%	$17.8M +155.6%	$-32.0M +40.7%	$-54.0M -30.7%	$-41.3M +12.4%	$-47.2M
Operating Income	$-17.5M -220.0%	$14.5M +139.6%	$-36.8M +51.3%	$-75.5M -24.9%	$-60.4M -135.1%	$-25.7M
EPS (Diluted)	$-2.39 -189.5%	$2.67 +155.9%	$-4.78 +52.2%	$-9.99 -1565.0%	$-0.60 -15.4%	$-0.52
Total Assets	$18.3M -55.8%	$41.4M -65.8%	$120.8M -32.1%	$177.8M +2.1%	$174.1M -17.0%	$209.7M
Operating Cash Flow	$-20.8M +58.7%	$-50.5M +3.8%	$-52.5M -7.7%	$-48.7M -52.5%	$-32.0M -193.3%	$34.3M

AI Insight: LITS Financial Trends

Lite Strategy remains pre-revenue with erratic profitability swings and sharply deteriorating equity base—Q4 2025 marked worst operating loss in two years.

• Company still generating zero revenue across all periods. Operating losses ranged from $3M to $30M quarterly, with Q4 2025 hitting $30M loss.

• Equity collapsed from $59M (Q4 2023) to $57M (Q1 2026), with a brief spike to $112M in Q3 2025 likely from capital injection, then fell again.

• Q1 2025 showed isolated profitability ($21M net income, $19M operating income), but immediately reversed; pattern suggests one-time gain, not operational turnaround.

⚠ Operating cash burn remains persistent and material ($2M–$18M per quarter). Q4 2025 cash burn of $2M despite $30M operating loss warrants investigation.

⚠ Equity volatility and capital structure instability suggest ongoing dilution or restructuring risk. Q1 2026 data missing—funding runway unclear.

AI Insight: LITS Ratio Trends

Lite Strategy swung to massive losses in Q4 2025, erasing nine quarters of gradual improvement and signaling a critical operational deterioration.

• ROE collapsed to -150.5% in Q4 2025, reversing steady recovery from -74.4% in Q4 2023 through -13.0% in Q3 2025.

• ROIC improved from -80.2% (Q4 2023) to -13.3% (Q3 2025), suggesting operational stabilization before Q4 reversal.

⚠ Q4 2025 ROE deterioration of -137.5pp versus Q3 2025 indicates major loss event or accounting adjustment requiring urgent clarification.

⚠ ROA gap unexplained in Q4 2025 (missing data) alongside ROE collapse—suggests either data anomaly or undisclosed material charge.

Get alerted when LITS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Lite Strategy, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of LITS

RENAISSANCE TECHNOLOGIES LLC
$2.0M1,744,700 sh
VANGUARD CAPITAL MANAGEMENT LLC
$1.2M1,043,313 sh
CITADEL ADVISORS LLC
$846.9K730,099 sh
TWO SIGMA INVESTMENTS, LP
$712.8K614,442 sh
GEODE CAPITAL MANAGEMENT, LLC
$465.7K401,091 sh
MARSHALL WACE, LLP
$386.9K333,508 sh
VANGUARD FIDUCIARY TRUST CO
$225.0K193,995 sh
SIMPLEX TRADING, LLC
$184.9K159,400 sh
BlackRock, Inc.
$183.2K157,891 sh
XTX Topco Ltd
$157.8K136,024 sh

Fund	Value	Shares
RENAISSANCE TECHNOLOGIES LLC	$2.0M	1,744,700
VANGUARD CAPITAL MANAGEMENT LLC	$1.2M	1,043,313
CITADEL ADVISORS LLC	$846.9K	730,099
TWO SIGMA INVESTMENTS, LP	$712.8K	614,442
GEODE CAPITAL MANAGEMENT, LLC	$465.7K	401,091
MARSHALL WACE, LLP	$386.9K	333,508
VANGUARD FIDUCIARY TRUST CO	$225.0K	193,995
SIMPLEX TRADING, LLC	$184.9K	159,400
BlackRock, Inc.	$183.2K	157,891
XTX Topco Ltd	$157.8K	136,024

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put LITS on your watchlist

Track score changes the day Lite Strategy, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is LITS a good stock to buy?

13F Pro's AI-powered analysis of Lite Strategy, Inc. (LITS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LITS are available on the LITS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own LITS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LITS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Lite Strategy, Inc.'s investment landscape.